BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

China

IASO Bio Secures First Approval Outside Mainland China for Equecabtagene Autoleucel in Macau

IASO Biotherapeutics ("IASO Bio"), a biopharmaceutical company focused on the discovery, development, manufacturing, and commercialization of innovative ce...

March 31, 2025 | News

Langhua Pharmaceutical Receives FDA EIR Following Successful cGMP Inspection for the Fourth Time

Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP...

March 31, 2025 | News

Henlius and Organon’s HLX11 Biosimilar of Pertuzumab Accepted for Review by European Medicines Agency

Shanghai Henlius Biotech, Inc. and Organon announced that the European Medicines Agency (EMA) has accepted a Marketing Authorization Appli...

March 31, 2025 | News

ZEISS and DORC Secure NMPA Approval in China for ILM-Blue®, Advancing Retinal Surgery Standards

ZEISS Medical Technology announced today that the ILM staining dye ILM-Blue® from DORC (Dutch Ophthalmic Research Center (International) B.V...

March 28, 2025 | News

Mouser Electronics Explores the Future of Brain-Computer Interfaces in Latest Empowering Innovation Together Series

Mouser Electronics, Inc., the authorized global distributor with the newest electronic components and industrial automation products, announced...

March 28, 2025 | News

Fangzhou Partners with Tencent to Launch AI Agent 2.0, Advancing AI-Driven Healthcare with DeepSeek Integration

Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leader in Internet healthcare solutions, announced a strategic collaboration with Tencent&nb...

March 27, 2025 | News

Sichuan Kelun-Biotech Gets Green Light for First Radionuclide-Drug Conjugate Clinical Trial

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company has received a clinical trial notice approving the invest...

March 26, 2025 | News

China’s Everest Gets FDA Clearance for First mRNA Cancer Vaccine EVM14

EVM14 received U.S. FDA clearance for its IND application, becoming Everest's first internally discovered program, and the first mRNA therapeutic cancer ...

March 25, 2025 | News

China’s Innovent Doses First Patient in Phase 3 Trial of HER2-Targeted ADC for Ovarian Cancer

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...

March 25, 2025 | Report

China’s AIM Vaccine Gets FDA Nod for mRNA Shingles Vaccine Trial

AIM Vaccine Co., developed mRNA shingles vaccine has recently received clinical trial approval from the U.S. Food and Drug Administration (FDA). As o...

March 25, 2025 | News

CStone Submits EMA Application to Expand Sugemalimab Use in Stage III Lung Cancer

CStone Pharmaceuticals ("CStone", HKEX: 2616), a biopharmaceutical company dedicated to developing innovative cancer therapies, announced the submiss...

March 25, 2025 | News

Shanghai ArkBio Completes Phase III Trial of AK0901 for Pediatric ADHD in China

Shanghai Ark Biopharmaceutical Co., Ltd. announced the successful completion of the Phase III clinical study of AK0901, a novel drug for the treatment of a...

March 25, 2025 | News

SineuGene Therapeutics Receives FDA IND Clearance for First-in-Class ALS Gene Therapy SNUG01

SineuGene Therapeutics Co., Ltd. ("SineuGene"), a clinical-stage biotech company pioneering innovative therapies for neurological disorders, announce...

March 25, 2025 | News

Ractigen Reports Promising Phase I Data for First-in-Class saRNA Therapy RAG-01 in Bladder Cancer

Ractigen Therapeutics, a clinical-stage biopharmaceutical company pioneering small activating RNA (saRNA) therapeutics, announced the presentation of...

March 25, 2025 | News

Stay Connected